What AI says about ADNI

ADNI is a longitudinal, multi-center observational study that collects clinical assessments, neuroimaging (MRI and PET), biofluids, genetics, and other omics data from participants. Its primary goal is to validate biomarkers for Alzheimer’s disease to inform clinical trials and understand disease progression. Researchers access ADNI data and biospecimens through the IDA platform, enabling data sharing to advance ADRD research.